{"name":"Ichnos Sciences SA","slug":"ichnos-sciences-sa","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"GBR 830","genericName":"GBR 830","slug":"gbr-830","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"GBR 830","genericName":"GBR 830","slug":"gbr-830","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2025-09-09","type":"pipeline","source":"Business Today","summary":"Glenmark Pharma shares rise 3% as arm receives $700 mn, more details - Business Today","headline":"Glenmark Pharma shares rise 3% as arm receives $700 mn, more details","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxOenhrZlhjRldvR1JMZUtRMTN1YkdlUHYzMHpyTkE1Q3Q0RTJNZjhocEhiV2VaMTJQZmx4LXZRcUhYXy0zZl9VMEVNaG1KTHlIMGMtc2UwWEdTdDFyR2dvUmtzMDFEeU84YVZyOU5FZ2ltM1lVWGt3WTFHY0k2YWdUTjBvZUJwc0lQSkxMNmZvOF9JdGpkUzNDQzlIOVJFc2tNYmltNFJmbXh5ZGw4Ylg0OE5nN0thZGFtRTJsYUVMVWI0R0Y4TEFXc1BqbUh2WUR6QXVRUzEycUs0X0JqNjVLeVJNSEdHQXQ0SHZ2Xw?oc=5","date":"2025-07-17","type":"deal","source":"upstox.com","summary":"Glenmark Pharma, a BSE 500 stock, has rallied 34% in 1 month! AbbVie's licensing deal a big positive - upstox.com","headline":"Glenmark Pharma, a BSE 500 stock, has rallied 34% in 1 month! AbbVie's licensing deal a big positive","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-11","type":"pipeline","source":"Republic World","summary":"Glenmark Pharma Share Price: 52-Week High & 10% Surge - What’s Driving Today’s Rally? - Republic World","headline":"Glenmark Pharma Share Price: 52-Week High & 10% Surge - What’s Driving Today’s Rally?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxNQXJxd2lLLS10YU83WVVyclI1SkFubTVIR2s3ODVVazdUdGNubWRBWGhVWnJRbXNHQlpyYkNsV1RsdFI0ZkFmeWI2djlrZjR6d0ZjakVzdkdLZ2RTd0VFSE9NVWozdGk0M1JWak51cmhROTVfX0g1YzNaTDRJQkg2S2Z5RDlVaVlkZGR0dVY2dUllczl3dEtHdWlWUnZxTGVWZFNEbGZUNlhZX2RSSTJDNkhlMFg1QkRicWRGVFZMY0VSMDA1OVhBSlB1ZFJteUY4MUhudTVSaTVDUFBQclFHLU10c3hJdllSU3c?oc=5","date":"2025-07-11","type":"deal","source":"upstox.com","summary":"Glenmark Pharma shares retreat after jumping 20% to hit record high after landmark deal worth $700 million - upstox.com","headline":"Glenmark Pharma shares retreat after jumping 20% to hit record high after landmark deal worth $700 million","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-10","type":"pipeline","source":"CNBC TV18","summary":"Glenmark Pharma's innovation arm signs exclusive licensing agreement with AbbVie for ISB 2001 - CNBC TV18","headline":"Glenmark Pharma's innovation arm signs exclusive licensing agreement with AbbVie for ISB 2001 - CNBC TV18","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-10","type":"pipeline","source":"CNBC TV18","summary":"Glenmark to retain ISB 2001 rights in India, emerging markets; AbbVie to lead global development: CMD Glenn Sa - CNBC TV18","headline":"Glenmark to retain ISB 2001 rights in India, emerging markets; AbbVie to lead global development: CMD Glenn Sa - CNBC TV","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-10","type":"deal","source":"Business Standard","summary":"Glenmark arm inks $700 million licensing deal with US-based AbbVie - Business Standard","headline":"Glenmark arm inks $700 million licensing deal with US-based AbbVie","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxOLXMtZlFJTmRmZVZ4YXA5bEdrVHpwTXMzR1VJallzekU0ZXhmUERqOTctUzh1b3FycmM2Ul9hSDYyUF9lSDZheDh6RTc3ZWF6WXlYaWpSZlFtc01IbFRvX3FLeVVqNzFDZmh1elZwR2F2QmR4RUh4WlJFWEQ1X3dGR3J3bTJ4Q2xkOHZXdVFRbE1rVzU3WktXRlE3T1RJUXQ3UUVmcXJMRUswYlYwRmVhM3JWekUxWWp6RnhTLVA3Rm1NSUJlM2pDclpFbThVMDFrOTFzeWUtaDMtVWFsZkdoMUVyVHpEdTVRakVwbFl6SXMwYjZUS3FRR04xYnNWMEk?oc=5","date":"2025-03-24","type":"pipeline","source":"PR Newswire UK","summary":"CARVYKTI Continued Performance Reflects Growing Confidence in CAR-T Therapies for Multiple Myeloma | DelveInsight - PR Newswire UK","headline":"CARVYKTI Continued Performance Reflects Growing Confidence in CAR-T Therapies for Multiple Myeloma | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAJBVV95cUxPR1RSdkJUVkFLWXdRVnRFdTVDTlFCdzM2ZDhzUHp6RjVWalg0UDZYWkQzT3Z1aG01Vm5NVGthTm83VzZXYVRuSWpBQ0tLQjA3RUZ5dTluUXdPVTl4NmxyTzB1TEJJNnRmRnNla0ZMSnNUZXAyOHB4MXFkOV8tZmpOZXlrZnBMX0dqZVB0OUtWQU9hTVBMNnlKUlVIc0pxWUhFVEtlTVpSVmNVaEl4Ni12NC1XSzhkNDNndDdkWS13WVkwYnNPbFQtczFMcnBhZ2syMkV6bkJRTXVZUmlGQlZja0dKcGtDSXlPWEFoc3pjQzVFcVp5SVJ2VzlwREMyUDVmSk5ZQjJHTzZCcnBSc0JUTVhLZEJHU2ZsTVJhb1o0VW53VHVs?oc=5","date":"2024-01-30","type":"pipeline","source":"prnewswire.com","summary":"Glenmark and Ichnos take a collaborative leap to accelerate innovation in Cancer Treatment with their alliance - 'Ichnos Glenmark Innovation' - prnewswire.com","headline":"Glenmark and Ichnos take a collaborative leap to accelerate innovation in Cancer Treatment with their alliance - 'Ichnos","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxONUNNbXBQSFU2cFJkQzM0WHJVdU4xblhQM3IwMlotS0xYbldQUF9ieUh0VmxGZk80SUdoUHp2bFlTSFlIUVQ2QUdxSl9UZ0szbktrUVFNcmdRZjNLWjVHXzJLMDd0QmdYcGFjRlRWbHBubnZsMGViMVQ2Qy16Y0d5LWp5bTBacDR2NnRwejVBb3hnV1FmdUFQbnNzOVR4M3o2eW5v?oc=5","date":"2019-10-22","type":"pipeline","source":"BioProcess International","summary":"Glenmark takes bi-specific stance in Ichnos spin-out - BioProcess International","headline":"Glenmark takes bi-specific stance in Ichnos spin-out","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxQc1pEaW1FNnV6bE83dXJnVWZBSG8wYUJBd1FmZHJRY3dmN3NFM0h1bUhsNmtUTGdGVkFRNVBfazdqT1V5YkY4dWVObDVTWkFjRm5QeDJ4eWZDcHctOXZyd2ZuZHRCNVE4dXhlUk5WeDZJS3k5VE9INUVEN0ZSMkFfLVVvejd5TFg5dTcwWElTYVlZbFdib3FDdUh3THN5OUhCc0hsTm1OeGwtdnBtUDVoV3lvNVpfUTBEWG81anZBb1UyeTVYMzdsX3l2YkE1Y2xUUEVpdGFTZ2E3ZnlHUlhRVU5vd3VTUQ?oc=5","date":"2019-10-15","type":"pipeline","source":"prnewswire.com","summary":"Ichnos Sciences Launches as New, Independent, Leading-Edge Biotech Dedicated to Outpacing Disease - prnewswire.com","headline":"Ichnos Sciences Launches as New, Independent, Leading-Edge Biotech Dedicated to Outpacing Disease","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}